A detailed history of Loomis Sayles & CO L P transactions in Danaher Corp stock. As of the latest transaction made, Loomis Sayles & CO L P holds 963,589 shares of DHR stock, worth $247 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
963,589
Previous 965,880 0.24%
Holding current value
$247 Million
Previous $223 Million 7.69%
% of portfolio
0.34%
Previous 0.34%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$224.58 - $256.19 $514,512 - $586,931
-2,291 Reduced 0.24%
963,589 $241 Million
Q4 2023

Feb 13, 2024

SELL
$185.1 - $233.13 $2.56 Million - $3.22 Million
-13,832 Reduced 1.41%
965,880 $223 Million
Q3 2023

Nov 09, 2023

SELL
$233.08 - $265.59 $931,387 - $1.06 Million
-3,996 Reduced 0.41%
979,712 $243 Million
Q2 2023

Aug 11, 2023

SELL
$224.99 - $256.14 $8.53 Million - $9.71 Million
-37,904 Reduced 3.71%
983,708 $236 Million
Q1 2023

May 11, 2023

SELL
$239.75 - $277.0 $2.83 Million - $3.27 Million
-11,804 Reduced 1.14%
1,021,612 $257 Million
Q4 2022

Feb 10, 2023

SELL
$241.42 - $282.29 $35.7 Million - $41.7 Million
-147,887 Reduced 12.52%
1,033,416 $274 Million
Q3 2022

Nov 14, 2022

SELL
$247.06 - $1507.4 $31.6 Million - $193 Million
-128,008 Reduced 9.78%
1,181,303 $305 Million
Q2 2022

Aug 05, 2022

SELL
$237.11 - $299.66 $6.92 Million - $8.75 Million
-29,197 Reduced 2.18%
1,309,311 $332 Million
Q1 2022

May 13, 2022

SELL
$257.27 - $315.76 $13.8 Million - $17 Million
-53,725 Reduced 3.86%
1,338,508 $393 Million
Q4 2021

Feb 14, 2022

SELL
$292.08 - $329.01 $28.8 Million - $32.4 Million
-98,617 Reduced 6.61%
1,392,233 $458 Million
Q3 2021

Nov 12, 2021

SELL
$272.21 - $332.43 $33.5 Million - $40.9 Million
-122,901 Reduced 7.62%
1,490,850 $454 Million
Q2 2021

Aug 13, 2021

BUY
$225.08 - $271.69 $34.8 Million - $42 Million
154,465 Added 10.58%
1,613,751 $433 Million
Q1 2021

May 17, 2021

SELL
$212.38 - $245.9 $2.53 Million - $2.93 Million
-11,910 Reduced 0.81%
1,459,286 $328 Million
Q4 2020

Feb 12, 2021

SELL
$212.5 - $245.46 $7.25 Million - $8.37 Million
-34,104 Reduced 2.27%
1,471,196 $327 Million
Q3 2020

Nov 12, 2020

BUY
$177.16 - $215.33 $11.4 Million - $13.9 Million
64,487 Added 4.48%
1,505,300 $324 Million
Q2 2020

Aug 14, 2020

SELL
$128.7 - $176.83 $38.2 Million - $52.5 Million
-296,818 Reduced 17.08%
1,440,813 $255 Million
Q1 2020

May 15, 2020

BUY
$121.39 - $169.05 $10.5 Million - $14.6 Million
86,591 Added 5.24%
1,737,631 $241 Million
Q4 2019

Feb 14, 2020

BUY
$133.47 - $153.48 $51.1 Million - $58.8 Million
382,882 Added 30.19%
1,651,040 $253 Million
Q3 2019

Nov 13, 2019

SELL
$135.4 - $146.47 $14.7 Million - $16 Million
-108,927 Reduced 7.91%
1,268,158 $183 Million
Q2 2019

Aug 14, 2019

BUY
$124.88 - $143.73 $15.9 Million - $18.3 Million
127,035 Added 10.16%
1,377,085 $197 Million
Q1 2019

May 15, 2019

BUY
$97.62 - $132.29 $5.03 Million - $6.82 Million
51,525 Added 4.3%
1,250,050 $165 Million
Q4 2018

Feb 14, 2019

BUY
$94.85 - $109.54 $27,980 - $32,314
295 Added 0.02%
1,198,525 $124 Million
Q3 2018

Nov 13, 2018

BUY
$98.13 - $108.9 $17.7 Million - $19.7 Million
180,755 Added 17.77%
1,198,230 $130 Million
Q2 2018

Aug 14, 2018

BUY
$96.1 - $103.24 $5.17 Million - $5.55 Million
53,805 Added 5.58%
1,017,475 $100 Million
Q1 2018

May 11, 2018

BUY
$92.16 - $103.8 $6.01 Million - $6.77 Million
65,183 Added 7.25%
963,670 $94.4 Million
Q4 2017

Feb 14, 2018

BUY
$85.26 - $94.62 $6.23 Million - $6.92 Million
73,090 Added 8.86%
898,487 $83.4 Million
Q3 2017

Nov 14, 2017

BUY
$79.29 - $88.45 $11.9 Million - $13.2 Million
149,452 Added 22.11%
825,397 $70.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
675,945
675,945 $57 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $187B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Loomis Sayles & CO L P Portfolio

Follow Loomis Sayles & CO L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.